Ident. | Authors (with country if any) | Title |
---|
000189 (2020) |
Yixian Liao [République populaire de Chine] ; Yilu Ye [République populaire de Chine] ; Sumei Li [République populaire de Chine] ; Yilian Zhuang [République populaire de Chine] ; Liye Chen [République populaire de Chine] ; Jianxin Chen [République populaire de Chine] ; Zining Cui [République populaire de Chine] ; Lijian Huo [République populaire de Chine] ; Shuwen Liu [République populaire de Chine] ; Gaopeng Song [République populaire de Chine] | Synthesis and SARs of dopamine derivatives as potential inhibitors of influenza virus PAN endonuclease. |
000351 (2020) |
Shiwen Ma [République populaire de Chine] ; Peng Gao [République populaire de Chine] ; Daru Lu [République populaire de Chine] ; Guoyu Wang [République populaire de Chine] | Prudently conduct the engineering and synthesis of the SARS-CoV-2 virus |
000554 (2020) |
Ting Xiao [République populaire de Chine] ; Jia-Fan Tang [République populaire de Chine] ; Ge Meng [République populaire de Chine] ; Christophe Pannecouque [Belgique] ; Yuan-Yuan Zhu [République populaire de Chine] ; Gen-Yan Liu [République populaire de Chine] ; Zhi-Qiang Xu [République populaire de Chine] ; Feng-Shou Wu [République populaire de Chine] ; Shuang-Xi Gu [République populaire de Chine] ; Fen-Er Chen [République populaire de Chine] | Indazolyl-substituted piperidin-4-yl-aminopyrimidines as HIV-1 NNRTIs: Design, synthesis and biological activities. |
000800 (2020) |
Chu-Wen Yang [Taïwan] ; Mei-Fang Chen [Taïwan] | Composition of human-specific slow codons and slow di-codons in SARS-CoV and 2019-nCoV are lower than other coronaviruses suggesting a faster protein synthesis rate of SARS-CoV and 2019-nCoV. |
000A83 (2019) |
Natacha S. Ogando [Pays-Bas] ; Francois Ferron [France, Allemagne] ; Etienne Decroly [France] ; Bruno Canard [France] ; Clara C. Posthuma [Pays-Bas] ; Eric J. Snijder [Pays-Bas] | The Curious Case of the Nidovirus Exoribonuclease: Its Role in RNA Synthesis and Replication Fidelity |
000A86 (2019) |
Kaijun Jin [République populaire de Chine] ; Yali Sang [République populaire de Chine] ; Sheng Han [République populaire de Chine] ; Erik De Clercq [Belgique] ; Christophe Pannecouque [Belgique] ; Ge Meng [République populaire de Chine] ; Fener Chen [République populaire de Chine] | Synthesis and biological evaluation of dihydroquinazoline-2-amines as potent non-nucleoside reverse transcriptase inhibitors of wild-type and mutant HIV-1 strains. |
000B58 (2019) |
Zhao Wang [République populaire de Chine] ; Zhao Yu [République populaire de Chine] ; Dongwei Kang [République populaire de Chine] ; Jian Zhang [République populaire de Chine] ; Ye Tian [République populaire de Chine] ; Dirk Daelemans [Belgique] ; Erik De Clercq [Belgique] ; Christophe Pannecouque [Belgique] ; Peng Zhan [République populaire de Chine] ; Xinyong Liu [République populaire de Chine] | Design, synthesis and biological evaluation of novel acetamide-substituted doravirine and its prodrugs as potent HIV-1 NNRTIs. |
000B59 (2019) |
Ji Yu [République populaire de Chine] ; Xiaowei Guo [République populaire de Chine] ; Samuel Desta [République populaire de Chine] ; Shuo Zhang [République populaire de Chine] ; Jian Zhang [République populaire de Chine] ; Xiao Ding [République populaire de Chine] ; Xiaohong Liang [République populaire de Chine] ; Haiyong Jia [République populaire de Chine] ; Xinyong Liu [République populaire de Chine] ; Peng Zhan [République populaire de Chine] | Design, Synthesis and Evaluation of Novel Heteroaryldihydropyrimidines Derivatives as Non-nucleoside Hepatitis B Virus Inhibitors by Exploring the Solvent-exposed Region. |
000B70 (2019) |
Ren-Jun Wu [République populaire de Chine] ; Kai-Xuan Zhou [République populaire de Chine] ; Haijin Yang [République populaire de Chine] ; Guo-Qing Song [République populaire de Chine] ; Yong-Hong Li [République populaire de Chine] ; Jia-Xin Fu [République populaire de Chine] ; Xiao Zhang [République populaire de Chine] ; Shu-Jing Yu [République populaire de Chine] ; Li-Zhong Wang [République populaire de Chine] ; Li-Xia Xiong [République populaire de Chine] ; Cong-Wei Niu [République populaire de Chine] ; Fu-Hang Song [République populaire de Chine] ; Haitao Yang [République populaire de Chine] ; Jian-Guo Wang [République populaire de Chine] | Chemical synthesis, crystal structure, versatile evaluation of their biological activities and molecular simulations of novel pyrithiobac derivatives. |
000C02 (2018) |
Dymytrii Listunov [France] ; Etienne Joly [France] ; Pauline Rulliere [France] ; H. Gaspard [France] ; V. Bernardes-Genisson [France] ; Y. Genisson [France] ; V. Maraval [France] ; R. Chauvin [France] | From natural to artificial antitumor lipidic alkynylcarbinols: Asymmetric synthesis, enzymatic resolution, and refined SARs |
000C28 (2018) |
Rong Zhou [République populaire de Chine] ; Yueguang Sun [République populaire de Chine] ; Hangbin Li [République populaire de Chine] ; Weili Long [République populaire de Chine] ; Xiaojian Liao [République populaire de Chine] ; Pengju Feng [République populaire de Chine] ; Shihai Xu [République populaire de Chine] | Synthesis and Biological Evaluation of Reniochalistatins A-E and a Reniochalistatin E Analogue. |
000C95 (2018) |
Rakhi Gawali [Inde] ; Jay Trivedi [Inde] ; Sujit Bhansali [Inde] ; Raghunath Bhosale [Inde] ; Dhiman Sarkar [Inde] ; Debashis Mitra [Inde] | Design, synthesis, docking studies and biological screening of 2-thiazolyl substituted -2,3-dihydro-1H-naphtho[1,2-e][1,3]oxazines as potent HIV-1 reverse transcriptase inhibitors. |
000C96 (2018) |
Alicia Regueiro-Ren ; Jacob J. Swidorski ; Zheng Liu ; Yan Chen ; Ny Sin ; Sing-Yuen Sit ; Jie Chen ; Brian L. Venables ; Juliang Zhu ; Beata Nowicka-Sans ; Tricia Protack ; Zeyu Lin ; Brian Terry ; Himadri Samanta ; Sharon Zhang ; Zhufang Li ; John Easter ; Brett R. Beno ; Vinod Arora ; Xiaohua S. Huang ; Sandhya Rahematpura ; Dawn D. Parker ; Roy Haskell ; Kenneth S. Santone ; Mark I. Cockett ; Mark Krystal ; Nicholas A. Meanwell ; Susan Jenkins ; Umesh Hanumegowda ; Ira B. Dicker | Design, Synthesis, and SAR of C-3 Benzoic Acid, C-17 Triterpenoid Derivatives. Identification of the HIV-1 Maturation Inhibitor 4-((1 R,3a S,5a R,5b R,7a R,11a S,11b R,13a R,13b R)-3a-((2-(1,1-Dioxidothiomorpholino)ethyl)amino)-5a,5b,8,8,11a-pentamethyl-1-(prop-1-en-2-yl)-2,3,3a,4,5,5a,5b,6,7,7a,8,11,11a,11b,12,13,13a,13b-octadecahydro-1 H-cyclopenta[ a]chrysen-9-yl)benzoic Acid (GSK3532795, BMS-955176). |
000D59 (2017) |
Kuanglei Wang [République populaire de Chine] ; Fei Yang [République populaire de Chine] ; Lihui Wang [République populaire de Chine] ; Kemin Liu [République populaire de Chine] ; Lu Sun [République populaire de Chine] ; Bin Lin [République populaire de Chine] ; Yaping Hu [République populaire de Chine] ; Boyu Wang [République populaire de Chine] ; Maosheng Cheng [République populaire de Chine] ; Yongshou Tian [République populaire de Chine] | Synthesis and biological evaluation of NH2-acyl oseltamivir analogues as potent neuraminidase inhibitors. |
000D60 (2017) |
Lu Yu [République populaire de Chine] ; Xiuhai Gan [République populaire de Chine] ; Dagui Zhou [République populaire de Chine] ; Fangcheng He [République populaire de Chine] ; Song Zeng [République populaire de Chine] ; Deyu Hu [République populaire de Chine] | Synthesis and Antiviral Activity of Novel 1,4-Pentadien-3-one Derivatives Containing a 1,3,4-Thiadiazole Moiety. |
000E50 (2017) |
Li Wang [République populaire de Chine] ; Bo-Bo Bao [République populaire de Chine] ; Guo-Qing Song [République populaire de Chine] ; Cheng Chen [République populaire de Chine] ; Xu-Meng Zhang [République populaire de Chine] ; Wei Lu [République populaire de Chine] ; Zefang Wang [République populaire de Chine] ; Yan Cai [République populaire de Chine] ; Shuang Li [République populaire de Chine] ; Sheng Fu [République populaire de Chine] ; Fu-Hang Song [République populaire de Chine] ; Haitao Yang [République populaire de Chine] ; Jian-Guo Wang [République populaire de Chine] | Discovery of unsymmetrical aromatic disulfides as novel inhibitors of SARS-CoV main protease: Chemical synthesis, biological evaluation, molecular docking and 3D-QSAR study |
000E67 (2017) |
Nam Nam Cheung [République populaire de Chine] ; Kin Kui Lai [République populaire de Chine] ; Jun Dai [République populaire de Chine] ; Kin Hang Kok [République populaire de Chine] ; Honglin Chen [République populaire de Chine] ; Kwok-Hung Chan [République populaire de Chine] ; Kwok-Yung Yuen [République populaire de Chine] ; Richard Yi Tsun Kao [République populaire de Chine] | Broad-spectrum inhibition of common respiratory RNA viruses by a pyrimidine synthesis inhibitor with involvement of the host antiviral response. |
000F05 (2016) |
Armand Gellis [France] ; Nicolas Primas [France] ; Sébastien Hutter [France] ; Gilles Lanzada [France] ; Vincent Remusat [France] ; Pierre Verhaeghe [France] ; Patrice Vanelle [France] ; Nadine Azas [France] | Looking for new antiplasmodial quinazolines: DMAP-catalyzed synthesis of 4-benzyloxy- and 4-aryloxy-2-trichloromethylquinazolines and their in vitro evaluation toward Plasmodium falciparum |
000F30 (2016) |
E. J. Snijder [Pays-Bas] ; E. Decroly [France] ; J. Ziebuhr [Allemagne] | The Nonstructural Proteins Directing Coronavirus RNA Synthesis and Processing |
000F42 (2016) |
Bo Su [République populaire de Chine] ; Chunlong Cai [République populaire de Chine] ; Meng Deng [République populaire de Chine] ; Qingmin Wang [République populaire de Chine] | Spatial Configuration and Three-Dimensional Conformation Directed Design, Synthesis, Antiviral Activity, and Structure-Activity Relationships of Phenanthroindolizidine Analogues. |
001007 (2016) |
Vathan Kumar [Taïwan] ; Kian-Pin Tan [Taïwan] ; Ying-Ming Wang [Taïwan] ; Sheng-Wei Lin [Taïwan] ; Po-Huang Liang [Taïwan] | Identification, synthesis and evaluation of SARS-CoV and MERS-CoV 3C-like protease inhibitors. |